Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-09

Clinical Trial Update: Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing the efficacy and safety of mirabegron for overactive bladder in Taiwan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirabegron (mirabegron)

Snippet

Sponsor: Buddhist Tzu Chi General Hospital | Conditions: Overactive Bladder Syndrome | Phase 3 | Status: UNKNOWN